Mice with selective TTP overexpression in hematopoietic cells were able to mitigate the CAIA inflammatory challenge, inducing symptoms similar to those found in human RA, with a significant reduction in the signs of joint inflammation. Here, ZFP36 is linked to rheumatoid arthritis.